Positive Data from the Danish National Patient Registry presented at the 2022 Nordic Urologisk Forening (NUF) Congress in Helsinki
Lower rates of bladder cancer recurrence and progression demonstrated in clinics with a high level of blue light cystoscopy (BLC[®]) use in primary patients Photocure sponsor of the Residents Day during the NUF congress Press Release – Oslo, Norway, June 13, 2022: Photocure ASA (OSE: PHO) announces that positive data from a Danish population registry study featuring nearly 10,000 bladder cancer patients was presented at the Nordisk Urologisk Forening (NUF) congress in Helsinki, Finland last week. NUF was being held June 8-11, 2022 as an in-person event for the first time since 2019.